While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see ...

LV thrombus is less of an issue now thanks to primary PCI and antithrombotics, but it still occurs in 9% of anterior MIs.

Liberal fluid intake was safe and suggestive of better health status: this should be enough to stop restricting patients to 1 ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

Additional research is needed to determine whether this is due to direct drug effects or underlying patient factors.

Mamas Mamas, Stefan Anker, and Volker Rudolph talk about their studies of MitraClip for functional MR in patients with heart ...

Disappointment over a cardiology board, an FDA approval, meeting news, and advice for practice—it’s all here this month.

The SINGLE SHOT CHAMPION study increases momentum for PFA as a first-line option for pulmonary vein isolation, say experts.

The prothrombin complex concentrate costs more than plasma, but may pay dividends by way of fewer adverse events.

The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...

Experts are dismayed, disappointed, and confused, but many say this isn’t the end of cerebral embolic protection for TAVI.

Cotemporary DES paired with FFR guidance and modern medical therapy may be what narrowed the gap, William Fearon says.